NEW YORK--(BUSINESS WIRE)--Following last week’s announcement by Cardinal Health that the company will sell its Pharmaceutical Technologies and Services segment (PTS) to The Blackstone Group, Blackstone has announced the appointment of George Fotiades, former CEO of PTS, and Aleksander Erdeljan, former CEO of R.P. Scherer, to the Board of PTS.
